Brett K. Haumann's most recent trade in Theravance Biopharma Inc was a trade of 35,672 Ordinary Shares done at an average price of $18.8 . Disclosure was reported to the exchange on Feb. 20, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Theravance Biopharma Inc | Brett K. Haumann | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.79 per share. | 20 Feb 2021 | 35,672 | 242,499 (0%) | 0% | 18.8 | 670,277 | Ordinary Shares |
Theravance Biopharma Inc | Brett K. Haumann | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.21 per share. | 20 Nov 2020 | 4,639 | 278,171 (0%) | 0% | 17.2 | 79,837 | Ordinary Shares |
Theravance Biopharma Inc | Brett K. Haumann | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.29 per share. | 20 Aug 2020 | 25,000 | 282,810 (0%) | 0% | 18.3 | 457,240 | Ordinary Shares |
Theravance Biopharma Inc | Brett K. Haumann | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.22 per share. | 20 Aug 2020 | 4,646 | 307,810 (0%) | 0% | 18.2 | 84,650 | Ordinary Shares |